![]() This presentation describes the market analysis of two emerging classes of biomarkers: Epigenetics-based and microRNA based. Novel Classes of Biomarkers for Personalized Medicine: Epigenetics and microRNAĮnal Razvi, Managing Director, Select Biosciences Inc, United States of America The new era of molecular diagnostics requires a new era of business models. Steven Bodovitz, Principal, Bioperspectives, United States of America Session: Commercial & Regulatory Perspectives We present a fast, highly versatile microfluidic platform which utilises mobile magnetic particles for performing surface-based assays in continuous flow within a fraction of the time required for conventional methods. Nicole Pamme, Professor in Analytical Chemistry, Stockholm University, Sweden Rapid Clinical Diagnostics in a Continuous Flow Lab on a Chip ![]() This talk will investigate the challenges faced when using molecular approaches as well as the clinical challenges they can potentially overcome. Molecular methods offer an ever increasing range of potential diagnostic and prognostic tools. ![]() Jim Huggett, Science Leader, LGC Group, United Kingdom The biochips allow timely detection of socially dangerous diseases, as cancer, cardiovascular illnesses, hereditary diseases and different infections.ĭiagnostic Challenges for the Next 10 Years Gel-based Microarrays in Clinical Diagnostics and Oncologyĭimitry Gryadunov, Postdoctoral Fellow, Engelhardt Institute of Molecular Biology, Russian FederationĪ technology of three-dimensional hydrogel microarrays (biochips) has been developed, patented, and implemented for practical medical diagnostics. ![]() Session: Clinical Applications of Molecular Diagnostics ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |